Search Results - Ghayas C. Issa

Refine Results
  1. 1
    Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm

    Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm by Ghayas C. Issa, Courtney D. DiNardo

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

    Nucleophosmin 1 Mutations in Acute Myeloid Leukemia by Jabra Zarka, Nicholas J. Short, Rashmi Kanagal‐Shamanna, Ghayas C. Issa

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Management of chronic myeloid leukemia in 2023 – common ground and common sense

    Management of chronic myeloid leukemia in 2023 – common ground and common sense by Jayastu Senapati, Koji Sasaki, Ghayas C. Issa, Jeffrey H. Lipton, Jerald P. Radich, Elias Jabbour, Hagop M. Kantarjian

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia

    Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia by Aram Bidikian, Hagop M. Kantarjian, Elias Jabbour, Nicholas J. Short, Keyur P. Patel, Farhad Ravandi, Koji Sasaki, Ghayas C. Issa

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease

    Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease by Wei‐Ying Jen, Hagop M. Kantarjian, Tapan M. Kadia, Courtney D. DiNardo, Ghayas C. Issa, Nicholas J. Short, Musa Yılmaz, Gautam Borthakur, Farhad Ravandi, Naval Daver

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Current status and research directions in acute myeloid leukemia

    Current status and research directions in acute myeloid leukemia by Hagop M. Kantarjian, Gautam Borthakur, Naval Daver, Courtney D. DiNardo, Ghayas C. Issa, Elias Jabbour, Tapan M. Kadia, Koji Sasaki, Nicholas J. Short, Musa Yılmaz, Farhad Ravandi

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia by Nicholas J. Short, Elias Jabbour, Koji Sasaki, Keyur P. Patel, Susan O’Brien, Jorge E. Cortés, Rebecca Garris, Ghayas C. Issa, Guillermo Garcia‐Manero, Rajyalakshmi Luthra, Deborah A. Thomas, Hagop M. Kantarjian, Farhad Ravandi

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101)

    Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101) by Eytan M. Stein, Ibrahim Aldoss, John F. DiPersio, Richard M. Stone, Martha Arellano, Galit Rosen, Michael L. Meyers, Yifan Huang, Steve Smith, Rebecca G. Bagley, Michael J. Thirman, Manish R. Patel, Ghayas C. Issa

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

    Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience by Kamal Chamoun, Hagop M. Kantarjian, Rami Atallah, Graciela Nogueras González, Ghayas C. Issa, Mary Beth Rios, Guillermo Garcia‐Manero, Gautam Borthakur, Farhad Ravandi, Nitin Jain, Naval Daver, Marina Konopleva, Courtney D. DiNardo, Tapan M. Kadia, Naveen Pemmaraju, Elias Jabbour, Jorge E. Cortés

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Hyper‐CVAD plus ponatinib versus hyper‐CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A propensity score analysis

    Hyper‐CVAD plus ponatinib versus hyper‐CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A propensity score... by Koji Sasaki, Elias Jabbour, Farhad Ravandi, Nicholas J. Short, Deborah A. Thomas, Guillermo Garcia‐Manero, Naval Daver, Tapan M. Kadia, Marina Konopleva, Nitin Jain, Ghayas C. Issa, Vicki Jeanis, Haim G. Moore, Rebecca Garris, Naveen Pemmaraju, Jorge E. Cortés, Susan O’Brien, Hagop M. Kantarjian

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Prognostic and therapeutic impacts of mutant <i>TP53</i> variant allelic frequency in newly diagnosed acute myeloid leukemia

    Prognostic and therapeutic impacts of mutant <i>TP53</i> variant allelic frequency in newly diagnosed acute myeloid leukemia by Nicholas J. Short, Guillermo Montalban‐Bravo, Hyunsoo Hwang, Jing Ning, Miguel J. Franquiz, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Courtney D. DiNardo, Farhad Ravandi, Guillermo Garcia‐Manero, Koichi Takahashi, Marina Konopleva, Naval Daver, Ghayas C. Issa, Michael Andreeff, Hagop M. Kantarjian, Tapan M. Kadia

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

    Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma by Amber Gibson, Adriana Trabal, David McCall, Sajad Khazal, Laurie Toepfer, Donna Bell, Michael Roth, Kris M. Mahadeo, César Núñez, Nicholas J. Short, Courtney D. DiNardo, Marina Konopleva, Ghayas C. Issa, Farhad Ravandi, Nitin Jain, Gautam Borthakur, Hagop M. Kantarjian, Elias Jabbour, Branko Cuglievan

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy

    Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy by Sangeetha Venugopal, Koichi Takahashi, Naval Daver, Abhishek Maiti, Gautam Borthakur, Sanam Loghavi, Nicholas J. Short, Maro Ohanian, Lucia Masárová, Ghayas C. Issa, Xuemei Wang, Bueso-Ramos Carlos, Musa Yılmaz, Tapan M. Kadia, Michael Andreeff, Farhad Ravandi, Marina Konopleva, Hagop M. Kantarjian, Courtney D. DiNardo

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax

    Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax by Àlex Bataller, Alexandre Bazinet, Courtney D. DiNardo, Abhishek Maiti, Gautam Borthakur, Naval Daver, Nicholas J. Short, Elias Jabbour, Ghayas C. Issa, Naveen Pemmaraju, Musa Yılmaz, Guillermo Montalban‐Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian, Tapan M. Kadia

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment

    Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment by Ghayas C. Issa, Hagop M. Kantarjian, Graciela Nogueras González, Gautam Borthakur, Guilin Tang, William G. Wierda, Koji Sasaki, Nicholas J. Short, Farhad Ravandi, Tapan M. Kadia, Keyur P. Patel, Raja Luthra, Alessandra Ferrajoli, Guillermo Garcia‐Manero, Mary Beth Rios, Sara Dellasala, Elias Jabbour, Jorge E. Cortés

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Inotuzumab ozogamicin in combination with low‐intensity chemotherapy (mini‐HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome‐negative acute lymphoblastic leukemia: A propensity score analysis

    Inotuzumab ozogamicin in combination with low‐intensity chemotherapy (mini‐HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy fo... by Elias Jabbour, Koji Sasaki, Farhad Ravandi, Nicholas J. Short, Guillermo Garcia‐Manero, Naval Daver, Tapan M. Kadia, Marina Konopleva, Nitin Jain, Jorge E. Cortés, Ghayas C. Issa, Jovitta Jacob, Monica Kwari, Philip A. Thompson, Rebecca Garris, Naveen Pemmaraju, Musa Yılmaz, Susan O’Brien, Hagop M. Kantarjian

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

    Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia by Nicholas J. Short, Keyur P. Patel, Maher Albitar, Miguel J. Franquiz, Rajyalakshmi Luthra, Rashmi Kanagal‐Shamanna, Feng Wang, Rita Assi, Guillermo Montalban‐Bravo, Jairo Matthews, Wanlong Ma, Sanam Loghavi, Koichi Takahashi, Ghayas C. Issa, Steven M. Kornblau, Elias Jabbour, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Zeev Estrov, Farhad Ravandi

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Poor outcomes associated with +der(22)t(9;22) and −9/9p in patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor

    Poor outcomes associated with +der(22)t(9;22) and −9/9p in patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase... by Nicholas J. Short, Hagop M. Kantarjian, Koji Sasaki, Farhad Ravandi, Heidi Ko, C. Cameron Yin, Guillermo Garcia‐Manero, Jorge E. Cortés, Rebecca Garris, Susan O’Brien, Keyur P. Patel, Maria Khouri, Deborah A. Thomas, Nitin Jain, Tapan M. Kadia, Naval Daver, Christopher B. Benton, Ghayas C. Issa, Marina Konopleva, Elias Jabbour

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Outcomes of acute lymphoblastic leukemia with <i>KMT2A</i> (<i>MLL</i>) rearrangement: the MD Anderson experience

    Outcomes of acute lymphoblastic leukemia with <i>KMT2A</i> (<i>MLL</i>) rearrangement: the MD Anderson experience by Guillaume Richard‐Carpentier, Hagop M. Kantarjian, Guilin Tang, C. Cameron Yin, Joseph D. Khoury, Ghayas C. Issa, Fadi G. Haddad, Nitin Jain, Farhad Ravandi, Nicholas J. Short, Courtney D. DiNardo, Koichi Takahashi, Marina Konopleva, Naval Daver, Tapan M. Kadia, Guillermo Garcia‐Manero, Rebecca Garris, Susan O’Brien, Elias Jabbour

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements

    Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements by Ghayas C. Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas J. Short, Fadi G. Haddad, Zhenya Tang, Keyur P. Patel, Branko Cuglievan, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Guillermo Garcia‐Manero, Marina Konopleva, Michael Andreeff, Hagop M. Kantarjian, Farhad Ravandi

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: